Division of Geriatrics and Palliative Care, Department of Medicine, NYU School of Medicine, New York, New York.
Division of Nephrology, Department of Medicine, NYU School of Medicine, New York, New York.
J Palliat Med. 2020 Feb;23(2):259-263. doi: 10.1089/jpm.2018.0647. Epub 2019 Jul 11.
Many patients with serious kidney disease have an elevated symptom burden, high mortality, and poor quality of life. Palliative care has the potential to address these problems, yet nephrology patients frequently lack access to this specialty. We describe patient demographics and clinical activities of the first 13 months of an ambulatory kidney palliative care (KPC) program that is integrated within a nephrology practice. Utilizing chart abstractions, we characterize the clinic population served, clinical service utilization, visit activities, and symptom burden as assessed using the Integrated Palliative Care Outcome Scale-Renal (IPOS-R), and patient satisfaction. Among the 55 patients served, mean patient age was 72.0 years (standard deviation [SD] = 16.7), 95% had chronic kidney disease stage IV or V, and 46% had a Charlson Comorbidity Index >8. The mean IPOS-R score at initial visit was 16 (range = 0-60; SD = 9.1), with a mean of 7.5 (SD = 3.7) individual physical symptoms (range = 0-15) per patient. Eighty-seven percent of initial visits included an advance care planning conversation, 55.4% included a medication change for symptoms, and 35.5% included a dialysis decision-making conversation. Overall, 96% of patients who returned satisfaction surveys were satisfied with the care they received and viewed the KPC program positively. A model of care that integrates palliative care with nephrology care in the ambulatory setting serves high-risk patients with serious kidney disease. This KPC program can potentially meet documented gaps in care while achieving patient satisfaction. Early findings from this program evaluation indicate opportunities for enhanced patient-centered palliative nephrology care.
许多患有严重肾脏疾病的患者都存在症状负担加重、死亡率高和生活质量差的问题。姑息治疗有可能解决这些问题,但肾脏科患者往往无法获得这种专业治疗。我们描述了一个肾脏姑息治疗(KPC)门诊项目的前 13 个月的患者人口统计学和临床活动情况,该项目整合在肾脏科实践中。通过图表摘录,我们描述了诊所服务的患者人群、临床服务的使用情况、就诊活动以及使用综合姑息治疗结局量表-肾脏(IPOS-R)评估的症状负担,以及患者满意度。在服务的 55 名患者中,平均患者年龄为 72.0 岁(标准差 [SD] = 16.7),95%患有慢性肾脏病第四或第五阶段,46%的患者 Charlson 合并症指数>8。初次就诊时的平均 IPOS-R 评分为 16(范围 0-60;SD = 9.1),每位患者的平均物理症状为 7.5(SD = 3.7)(范围 0-15)。87%的初次就诊包括预先护理计划谈话,55.4%包括针对症状的药物改变,35.5%包括透析决策谈话。总体而言,96%返回满意度调查的患者对他们所接受的护理感到满意,并对 KPC 项目持积极态度。一种将姑息治疗与肾脏科护理相结合的门诊护理模式为患有严重肾脏疾病的高危患者提供服务。该 KPC 项目可以潜在地满足已记录的护理差距,同时实现患者满意度。该项目评估的早期结果表明,有机会加强以患者为中心的姑息性肾脏科护理。